Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
ValiRx plc ( (GB:VAL) ) has provided an update.
ValiRx PLC has announced a change in major holdings as Peel Hunt LLP has adjusted its voting rights in the company to below 10%. This shift in holdings, effective from January 14, 2025, reflects a decrease from their previous position of over 10%, potentially impacting the company’s shareholder dynamics and future strategic decisions.
More about ValiRx plc
ValiRx PLC is a UK-based company operating in the biotechnology sector, focusing primarily on the development of diagnostic and therapeutic products for oncology and women’s health.
YTD Price Performance: -7.05%
Average Trading Volume: 7,837,998
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £2.71M
For an in-depth examination of VAL stock, go to TipRanks’ Stock Analysis page.
